REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/04/2026
Back to search
Official data from USPTO
EVOTEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EVOTEC
ST13
US500000074259734Class
1, 5, 9, 42
Filing
74259734
Registration
2041534
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/05/2026
Trademark type
Word
Nice classes
1, 5, 9, 42
Filing date
03/27/1992
Registration date
03/04/1997
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2017
Last transaction
03/05/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
61
Owner location
HAMBURG, EU
Examiner
SHANAHAN, PATRICK
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
E. S. (pessoa física)
EVOTEC AG
EVOTEC OAI AG
EVOTEC BIOSYSTEMS GMBH
DIAGEN Institut fur molekularbiologische Diagnostik GmbH
Representatives
Lawrence E. Abelman ABELMAN FRAYNE & SCHWAB
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemicals for commercial and scientific purposes; namelybiologically active proteins and nucleic acids with affine and/or enzymatic properties such as enzymes or ribozymes; namelyin vitro generated or optimized enzymespolymeraseshydrolasesligasesisomerasesfor in vitro biochemical conversions; in vitro generated or optimized polypeptides or proteins with specific binding properties for distinct target molecules for analytical or preparative purposes; polymers based on unnatural monomeric building blocks; and ribozymes for biological inactivation or target nucleic sequences
Class 5
pharmaceutical and veterinary-medical productsfor the purpose of specific complex formation with target molecules for analytical and therapeutic purposesfor diagnostic purposesfor activating or inactivating a biological responsefor drug targeting and target inactivation or activation; namelyin vitro generated or optimized enzymesribozymesaffinity peptidesproteins; polymers based on unnatural monomeric building blocks and their respective precursor molecules
Class 9
scientific apparatusesinstruments and automated laboratory instrumentsfor the production and preparation of biologically active substances such as proteins and/or nucleic acids with enzymatic and/or affine properties; namelyfor ultra sensitive target molecule detectionfor defining thermodynamic and kinetic reaction parametersfor parallel handling and processing of large arrays of liquid samplesfor handling small target volumes in the micro- to pico-liter rangefor single molecule detection and analysisfor polymer sequencingfor screening of biologically and pharmaceutically active substancesfor use in humanplantveterinary diagnosis
Class 42
consultation and research in the field of molecular biology
Publications
History of USPTO decisions and trademark events.
39 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/25/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/28/2017
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
04/28/2017
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
04/28/2017
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
04/28/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/28/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
03/06/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/18/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/19/2007
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/19/2007
PLGL
ASSIGNED TO PARALEGAL
04/19/2007
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
02/27/2007
E89R
TEAS SECTION 8 & 9 RECEIVED
02/27/2007
CFIT
CASE FILE IN TICRS
12/28/2006
CORV
REVIEW OF CORRESPONDENCE COMPLETE
11/25/2006
PAPER RECEIVED
08/21/2006
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
05/09/2006
CORV
REVIEW OF CORRESPONDENCE COMPLETE
05/06/2006
FAXX
FAX RECEIVED
02/21/2006
PRA8
RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8
02/25/2004
FAXX
FAX RECEIVED
02/25/2004
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
11/18/2003
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
09/03/2003
ES8R
TEAS SECTION 8 RECEIVED
09/03/2003
R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/1997
1.BD
Sec. 1(B) CLAIM DELETED
12/13/1996
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/13/1996
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/22/1996
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/18/1996
PUBO
PUBLISHED FOR OPPOSITION
12/19/1995
NPUB
NOTICE OF PUBLICATION
11/17/1995
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/1994
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/1994
CNSI
INQUIRY AS TO SUSPENSION MAILED
02/22/1994
CNSL
LETTER OF SUSPENSION MAILED
02/10/1993
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/1992
CNRT
NON-FINAL ACTION MAILED
06/08/1992
DOCK
ASSIGNED TO EXAMINER
05/21/1992
Continuous trademark protection
Get notified about every new filing that threatens EVOTEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.